eMedCodes logo

Atripla - efavirenz, emtricitabine, and tenofovir disoproxil fumarate

Navigation: NDC > Supplier starting with: B > BRISTOL MYERS SQUIBB & GILEAD SCIENCES, LLC
Field Value
NDC Code: 15584-0101
Proprietary Name: Atripla
Suffix:
Non-Proprietary Name: efavirenz, emtricitabine, and tenofovir disoproxil fumarate
Dosage Form: TABLET, FILM COATED
Method: ORAL
Original Marketing Date: 20-07-2006
Category Name: NDA
Application Number: NDA021937
Labeler: BRISTOL MYERS SQUIBB & GILEAD SCIENCES, LLC
Substance Name: EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Active Numerator Strength: 600; 200; 300
Active Ingredient Unit: mg/1; mg/1; mg/1
Pharm Classes: Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]
DEA Schedule: